Phase I study of irofulven (MGI 114), an acylfulvene illudin analog, in patients with acute leukemia (Q43567634)
Jump to navigation
Jump to search
scientific article published in January 2001
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I study of irofulven (MGI 114), an acylfulvene illudin analog, in patients with acute leukemia |
scientific article published in January 2001 |
Statements
1 reference
Phase I study of irofulven (MGI 114), an acylfulvene illudin analog, in patients with acute leukemia (English)
1 reference
Giles F
1 reference
Cortes J
1 reference
Garcia-Manero G
1 reference
Kornblau S
1 reference
Estey E
1 reference
Kwari M
1 reference
Murgo A
1 reference
Kantarjian H
1 reference
1 January 2001
1 reference
1 reference
19
1 reference
1
1 reference
13-20
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference